At Vanguard Diagnostics, we strive to enrich our portfolio continuously.
Our flagship product line is Hematology wherein we offer a complete solution to the customer constituting reagents, controls, calibrators and an analyzer.
We have developed, manufactured and marketed reagents over 20 models of Hematology analyzers, in a short span of five years.
We assign value sheets for Hematology Controls on analyzers that do not have one. This was an unmet need of the market which is being fulfilled by Vanguard.
Products Manufactured by Vanguard Diagnostics
In addition, we manufacture rapid card tests for communicable tropical infections like Malaria, Dengue, Chikungunya, Typhoid and Leptospirosis.
Our passion for branching into the adjacent space, led us to become the singular company in India that provides high-caliber, equivalent solutions for Flow Cytometers.
We have a basket of clinical chemistry reagents for diagnosing Diabetes, Liver & Kidney diseases.
The Covid-19 pandemic has put the technical and scientific abilities of the Indian in-vitro Diagnostics (IVD) industry to the test, since March, 2020. The industry has responded to the need of the hour swiftly, scientifically, strongly and successfully.
Since the month of March this year, the market started buzzing with the launch of novel Indian products for the detection of Covid-19. Today there are more than 30 Indian IVD companies that have introduced indigenous kits based on the Gold Standard, RT PCR technology and over 15 companies who have developed the antibody detection tests for Covid-19.
